跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Lidamycin
首页
药物
Lidamycin
Lidamycin
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Lidamycin prodrug, preparation method and application of lidamycin prodrug in preparation of antitumor drugs
申请人: INST MED BIOTECHNOLOGY CAMS
优先权: 2022
CN
Conjugate of Lidamycin with active fragment of monoclonal antibody
申请人: INST OF MEDICAL BIO TECHNOLOGY
优先权: 2001
CN
Single chain antibody-lidamycin fusion protein ER (Fv-LDP) targeting EGFR
申请人: INST MEDICINAL BIOTECHNOLOGY
优先权: 2009
CN
Coupled substance between Lidamycin and segments of monoclonal antibody 3G11, 3G11Fab'
申请人: INST OF MEDICINE BIOLOG TECHNO
优先权: 2005
CN
Method for reforming lidamycin-producing bacteria by means of gene substitution technology
申请人: INST OF BIOLOG TECHNOLOGY CHIN
优先权: 2007
CN
Recombinant fusion protein of IL3 and Lidamycin, preparation method and application thereof
申请人: INST OF HEMATOLOGY & BLOOD DISEASES HOSPITAL CHINESE ACADEMY OF MEDICAL SCIENCES & PEKING UNION MEDI
优先权: 2011
CN
High-yield bacterial strain C-1027-20 for preparing Lidamycin as antineoplastic antibiotic
申请人: INST OF MEDICAL BIO TECHNOLOGY
优先权: 2002
CN
Fusion protein of type IV collagenase resistant single chain antibody and Lidamycin agon protein
申请人: INST MEDICINAL BIOTECHNOLOGY
优先权: 2001
CN
2 件公开
药物
反馈